English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In prior studies a heteroantiserum to a surface membrane component termed TH2 was used to define two subsets of human T cells (TH2 + and TH2 - ), which were found to express distinct sets of activitiesin vitro . In the present studies we prepared monoclonal antibodies to surface determinants that are restricted to T cells belonging to each of these two subsets. Two antibodies, termed αLeu-2a and αLeu-2b, which seem to define the same surface antigen identified by the original TH2 antiserum, reacted with 57-84% of thymocytes and 22-46% of the erythrocyte-rosette-forming cells (ERF-C) in peripheral blood. Two other monoclonal antibodies, termed αLeu-3a and αLeu-3b, reacted with the same subpopulation of thymocytes (78-89%) and peripheral blood ERF-C (47-78%) but, unlike αLeu-2a and αLeu-2b, did not exhibit cross-blocking; i.e., labeling cells with αLeu-3a did not inhibit the subsequent binding of αLeu-3b. T cells reactive with αLeu-2a were shown to be unreactive with αLeu-3a, indicating that two separate subpopulations of T cells, Leu-2 (formerly TH2 + ) and Leu-3 (TH2 - ) T cells, were thereby defined. These two T cell subsets make up the subpopulation of ERF-C (80-95%) previously defined by a monoclonal antibody to a T cell membrane antigen (Leu-1) that has a thymus-dependent distribution on normal lymphocytes but is expressed by some surface-immunoglobulin-positive (sIg+ ) leukemic lymphocytes. None of the Leu antibodies reported here reacted with sIg+ , Leu-1+ leukemic cells, nor did they react with normal hematopoietic cells or lymphoid cells that had surface markers characteristic of B cells. Studies of the blocking effects of Leu antibodies on killing in cell-mediated lympholysis by effector T cells were carried out in the absence of complement. These experiments established the following points: (i ) αLeu-2a abolished the killing by cytotoxic T cells of allogeneic phytohemagglutinin-stimulated blasts, (ii ) inhibition of killing by αLeu-2b was markedly less than inhibition by αLeu-2a, and (iii ) other antibodies, including αLeu-1, αLeu-3a, and αLeu-3b, had little or no effect on killing in cell-mediated lympholysis. The relevance of these findings to prior studies done in the mouse and in man are discussed.

Thymus-dependent membrane antigens in man: Inhibition of cell-mediated lympholysis by monoclonal antibodies to T H 2 antigen

Thymus-dependent membrane antigens in man: Inhibition of cell-mediated lympholysis by monoclonal antibodies to T _{H ₂} antigen